Dose-Dependent Cognitive Decline, Anxiety, and Locomotor Impairments Induced by Doxorubicin: Evidence from an Animal Model

Dose-Dependent Cognitive Decline, Anxiety, and Locomotor Impairments Induced by Doxorubicin: Evidence from an Animal Model

Cognitive impairment and anxiety are common side effects of chemotherapy, particularly with the use of doxorubicin (DOX), known as “chemobrain”. This study aimed to examine the dose-dependent effects of DOX on cognitive decline, anxiety, and locomotor activity in healthy female Wistar rats. The rats...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ângela Amaro-Leal, Ana I. Afonso, Filipa Machado, Liana Shvachiy, Isabel Rocha, Tiago F. Outeiro, Vera Geraldes
Format:	Article
Language:	English
Published:	MDPI AG 2024-11-01
Series:	Biology
Subjects:	doxorubicin anxiety chemotherapy-induced cognitive impairment cognitive dysfunction
Online Access:	https://www.mdpi.com/2079-7737/13/11/939
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prevalence of Sleep Deprivation and Cognitive Impairment in Cancer Patients Undergoing Chemotherapy
by: Sakshi Heda, et al.
Published: (2024-07-01)

Investigation of Doxorubicin Efficiency in Some Hematological Parameters in Women with Breast Cancer in Iraq
by: Hanan B. Saadon
Published: (2024-12-01)

Olfactory Identification as a Biomarker for Cognitive Impairment: Insights from Healthy Aging, Subjective Cognitive Decline, and Mild Cognitive Impairment
by: Jaime Bouhaben, et al.
Published: (2024-11-01)

Efficacy and safety of pegylated liposomal doxorubicin and epirubicin as neoadjuvant chemotherapy for breast cancer
by: Yuanyuan Shen, et al.
Published: (2024-12-01)

Trajectory of Cognitive Decline After Incident Heart Failure Hospitalization: Findings From the REGARDS Study
by: Madeline R. Sterling, et al.
Published: (2024-09-01)

Frequency, sociodemographic, and neuropsychological features of patients with subjective cognitive decline diagnosed using different neuropsychological criteria
by: Pedro Câmara Pestana, et al.
Published: (2024-12-01)

A summary of the best evidence for story therapy to delay cognitive decline in the elder-ly with mild to moderate cognitive impairment
by: Chen SUN, et al.
Published: (2022-12-01)

Exploring the Link between Motor Cognitive Risk Syndrome and Cognitive Decline: Research Progress
by: Chen Lei, et al.
Published: (2024-11-01)

The supramolecular processing of liposomal doxorubicin hinders its therapeutic efficacy in cells
by: Annalisa Carretta, et al.
Published: (2024-09-01)

A Principal Component Analysis of Metabolome and Cognitive Decline Among Japanese Older Adults: Cross-sectional Analysis Using Tohoku Medical Megabank Cohort Study Data
by: Sakura Kiuchi, et al.
Published: (2025-01-01)

Investigation of the efficacy of tyrosol on doxorubicin-induced acute cardiotoxicity in rats
by: Mustafa Cellat, et al.
Published: (2022-09-01)

Polydopamine-functionalized calcium-deficient hydroxyapatite 3D-printed scaffold with sustained doxorubicin release for synergistic chemo-photothermal therapy of osteosarcoma and accelerated bone regeneration
by: Lu Wang, et al.
Published: (2024-12-01)

Seeing through “brain fog”: neuroimaging assessment and imaging biomarkers for cancer-related cognitive impairments
by: Quanquan Gu, et al.
Published: (2024-11-01)

Exploring Sex-Based Neuropsychological Outcomes in Pediatric Brain Cancer Survivors: A Pilot Study
by: Chiara Colliva, et al.
Published: (2024-11-01)

Effect of pimobendan on cytokine levels in doxorubicin-induced cardiotoxicity
by: Burak Dik, et al.

Periodontal Indices as Predictors of Cognitive Decline: Insights from the PerioMind Colombia Cohort
by: Catalina Arévalo-Caro, et al.
Published: (2025-01-01)

Association Between Severe Periodontitis and Cognitive Decline in Older Adults
by: Yash Brahmbhatt, et al.
Published: (2024-12-01)

Enhancement of Doxorubicin Efficacy by Bacopaside II in Triple-Negative Breast Cancer Cells
by: Sima Kianpour Rad, et al.
Published: (2025-01-01)

Exploring the Association Between Cognitive Decline and Triglyceride‐Glucose Index: A Systematic Review and Meta‐Analysis
by: Elina Ghondaghsaz, et al.
Published: (2024-11-01)

Association of low socioeconomic status with cognitive decline among older persons in underdeveloped areas in China – a data analysis of the Gansu aging study
by: Juxia Zhang, et al.
Published: (2024-11-01)

Streptomyces-derived nano-doxorubicin: Clinical status and patents granted
by: Kaur Prabhjot, et al.
Published: (2024-01-01)

Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism, biomarkers and management
by: Mohd Amaan, et al.
Published: (2024-12-01)

Evolution of Cognitive Disorders in Patients with Mild Cognitive Impairment (MCI) After Ischemic Stroke: Secondary Data Analysis from the Improved Health Care in Neurology and Psychiatry—Longer Life (IHCNP) Study
by: Dragoș-Cătălin Jianu, et al.
Published: (2024-11-01)

Event-Related Potentials Study of Cognitive Functions in Patients with Post-Stroke Cognitive Impairment
by: XU Peiao, et al.
Published: (2024-01-01)

Event-Related Potentials Study of Cognitive Functions in Patients with Post-Stroke Cognitive Impairment
by: XU Peiao, et al.
Published: (2024-06-01)

Effect of Vigorous-Intensity Physical Activity on Incident Cognitive Impairment in High-Risk Hypertension.
by: Kazibwe, Richard, et al.
Published: (2024)

The role of circRNAs in resistance to doxorubicin
by: Mahla Sanati, et al.
Published: (2024-11-01)

Histopathological evaluation of the effects of thymoquinone and resveratrol on the liver in rats administered doxorubicin
by: Mehmet Burak Ates, et al.
Published: (2022-09-01)

Analysis of doxorubicin and fullerenol in rat serum by micellar electrokinetic capillary chromatography
by: Injac Rade, et al.
Published: (2024-09-01)

Migraine and cognitive dysfunction: a narrative review
by: Catarina Fernandes, et al.
Published: (2024-12-01)

Effects of aerobic, strength, and combined exercise on cognitive functions in older adults: a systematic review
by: Enrique Cerda-Vega, et al.
Published: (2024-11-01)

Profile of non-invasive physical health indicators associated with cognitive performance in Chinese older adults: evidence from the China Health and Retirement Longitudinal Study
by: Xiyu Wei, et al.
Published: (2025-02-01)

Stability study of oxaliplatin and doxorubicin for intraperitoneal administration with hyperthermia
by: V. Escudero-Ortiz, et al.
Published: (2014-05-01)

A systematic review and meta-analysis of the impact of transcranial direct current stimulation on cognitive function in older adults with cognitive impairments: the influence of dosage parameters
by: Thatchaya Prathum, et al.
Published: (2025-02-01)

Natural epigallocatechin-3-gallocarboxylate nanoformulation loaded doxorubicin to construct a novel and low cardiotoxicity chemotherapeutic drug for high-efficiency breast cancer therapy
by: Ke Wang, et al.
Published: (2024-12-01)

Mitophagy in Doxorubicin-Induced Cardiotoxicity: Insights into Molecular Biology and Novel Therapeutic Strategies
by: Heng Zhang, et al.
Published: (2024-12-01)

Determination of protective effectiveness of nerium oleander distillation in doxorubicin-induced organ damages
by: Burak Dik, et al.

Titanium nanostructure mitigating doxorubicin–induced testicular toxicity in rats via regulating major autophagy signaling pathways
by: Rehab M. Abdel-Megeed, et al.
Published: (2025-06-01)

Retinal thickness predicts the risk of cognitive decline over five years
by: Leila Sara Eppenberger, et al.
Published: (2024-12-01)

Double Encapsulation of Resveratrol and Doxorubicin in Composite Nanogel—An Opportunity to Reduce Cardio- and Neurotoxicity of Doxorubicin
by: Lyubomira Radeva, et al.
Published: (2024-10-01)